Dentsply Sirona (XRAY) | Financial Analysis & Statements
Dentsply Sirona Inc. Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
961.0M
Gross Profit
443.0M
46.10%
Operating Income
25.0M
2.60%
Net Income
-145.0M
-15.09%
Balance Sheet Metrics
Total Assets
5.4B
Total Liabilities
4.1B
Shareholders Equity
1.3B
Debt to Equity
3.05
Cash Flow Metrics
Operating Cash Flow
-47.0M
Free Cash Flow
60.0M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Dentsply Sirona Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 3.7B | 3.8B | 4.0B | 3.9B | 4.2B |
| Cost of Goods Sold | 1.8B | 1.8B | 1.9B | 1.8B | 1.9B |
| Gross Profit | 1.8B | 2.0B | 2.1B | 2.1B | 2.3B |
| Gross Margin % | 50.0% | 51.6% | 52.6% | 54.2% | 55.5% |
| Operating Expenses | |||||
| Research & Development | 150.0M | 165.0M | 184.0M | 174.0M | 171.0M |
| Selling, General & Administrative | 1.4B | 1.6B | 1.6B | 1.6B | 1.6B |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 1.6B | 1.8B | 1.8B | 1.8B | 1.7B |
| Operating Income | 252.0M | 188.0M | 282.0M | 357.0M | 625.0M |
| Operating Margin % | 6.8% | 5.0% | 7.1% | 9.1% | 14.8% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 88.0M | 69.0M | 81.0M | 65.0M | 61.0M |
| Other Non-Operating Income | -650.0M | -1.1B | -376.0M | -1.3B | -19.0M |
| Pre-tax Income | -486.0M | -936.0M | -175.0M | -1.1B | 545.0M |
| Income Tax | 112.0M | -26.0M | -43.0M | -105.0M | 134.0M |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 24.6% |
| Net Income | -598.0M | -910.0M | -132.0M | -950.0M | 411.0M |
| Net Margin % | -16.2% | -24.0% | -3.3% | -24.2% | 9.7% |
| Key Metrics | |||||
| EBITDA | 596.0M | 528.0M | 620.0M | 648.0M | 969.0M |
| EPS (Basic) | $-3.00 | $-4.48 | $-0.62 | $-4.41 | $1.93 |
| EPS (Diluted) | $-3.00 | $-4.48 | $-0.62 | $-4.41 | $1.91 |
| Basic Shares Outstanding | 199400000 | 203200000 | 212000000 | 215500000 | 218400000 |
| Diluted Shares Outstanding | 199400000 | 203200000 | 212000000 | 215500000 | 218400000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Dentsply Sirona Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 326.0M | 272.0M | 334.0M | 365.0M | 339.0M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 688.0M | 556.0M | 695.0M | 632.0M | 750.0M |
| Inventory | 642.0M | 564.0M | 624.0M | 627.0M | 515.0M |
| Other Current Assets | 150.0M | 153.0M | 113.0M | 88.0M | 84.0M |
| Total Current Assets | 2.0B | 1.7B | 2.0B | 1.9B | 1.9B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 139.0M | 136.0M | 178.0M | 200.0M | 198.0M |
| Goodwill | 3.3B | 4.4B | 6.6B | 7.3B | 10.3B |
| Intangible Assets | 974.0M | 1.2B | 1.7B | 1.9B | 2.3B |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 284.0M | 301.0M | 276.0M | 198.0M | 121.0M |
| Total Non-Current Assets | 3.4B | 4.0B | 5.4B | 5.8B | 7.4B |
| Total Assets | 5.4B | 5.8B | 7.4B | 7.6B | 9.2B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 300.0M | 241.0M | 305.0M | 279.0M | 262.0M |
| Short-term Debt | 360.0M | 595.0M | 378.0M | 172.0M | 232.0M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 30.0M | 12.0M | 18.0M | 19.0M | 3.0M |
| Total Current Liabilities | 1.3B | 1.6B | 1.4B | 1.2B | 1.3B |
| Non-Current Liabilities | |||||
| Long-term Debt | 2.1B | 1.7B | 1.9B | 2.0B | 2.1B |
| Deferred Tax Liabilities | 94.0M | 129.0M | 228.0M | 287.0M | 391.0M |
| Other Non-Current Liabilities | 544.0M | 415.0M | 502.0M | 399.0M | 528.0M |
| Total Non-Current Liabilities | 2.7B | 2.2B | 2.7B | 2.7B | 3.0B |
| Total Liabilities | 4.1B | 3.8B | 4.1B | 3.8B | 4.2B |
| Equity | |||||
| Common Stock | 3.0M | 3.0M | 3.0M | 3.0M | 3.0M |
| Retained Earnings | -1.6B | -835.0M | 205.0M | 456.0M | 1.5B |
| Treasury Stock | 3.1B | 3.1B | 2.9B | 2.6B | 2.5B |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 1.3B | 1.9B | 3.3B | 3.8B | 5.0B |
| Key Metrics | |||||
| Total Debt | 2.5B | 2.3B | 2.3B | 2.1B | 2.3B |
| Working Capital | 680.0M | 157.0M | 548.0M | 723.0M | 591.0M |
Balance Sheet Composition
Dentsply Sirona Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -598.0M | -910.0M | -132.0M | -950.0M | 411.0M |
| Depreciation & Amortization | 352.0M | 349.0M | 343.0M | 328.0M | 346.0M |
| Stock-Based Compensation | 33.0M | 39.0M | 46.0M | 59.0M | 48.0M |
| Working Capital Changes | -141.0M | 96.0M | -15.0M | -39.0M | -211.0M |
| Operating Cash Flow | -334.0M | -571.0M | 140.0M | -780.0M | 576.0M |
| Investing Activities | |||||
| Capital Expenditures | - | - | 7.0M | 0 | 0 |
| Acquisitions | 0 | 0 | 13.0M | 0 | -220.0M |
| Investment Purchases | -14.0M | -12.0M | - | - | - |
| Investment Sales | 10.0M | 1.0M | 39.0M | 13.0M | 2.0M |
| Investing Cash Flow | -1.0M | -17.0M | 60.0M | 11.0M | -216.0M |
| Financing Activities | |||||
| Share Repurchases | 0 | -250.0M | -300.0M | -150.0M | -200.0M |
| Dividends Paid | -128.0M | -126.0M | -116.0M | -104.0M | -92.0M |
| Debt Issuance | 553.0M | 1.0M | 0 | 6.0M | 16.0M |
| Debt Repayment | -918.0M | -88.0M | -7.0M | -2.0M | -297.0M |
| Financing Cash Flow | -851.0M | -302.0M | -307.0M | -335.0M | -430.0M |
| Free Cash Flow | 104.0M | 281.0M | 228.0M | 368.0M | 515.0M |
| Net Change in Cash | -1.2B | -890.0M | -107.0M | -1.1B | -70.0M |
Cash Flow Trend
Dentsply Sirona Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-3.93
Forward P/E
7.85
Price to Book
1.81
Price to Sales
0.66
PEG Ratio
0.06
Profitability Ratios
Profit Margin
-16.25%
Operating Margin
1.77%
Return on Equity
-36.43%
Return on Assets
2.74%
Financial Health
Current Ratio
1.51
Debt to Equity
185.00
Beta
1.00
Per Share Data
EPS (TTM)
$-3.00
Book Value per Share
$6.71
Revenue per Share
$18.46
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| XRAY | 2.4B | -3.93 | 1.81 | -36.43% | -16.25% | 185.00 |
| Intuitive Surgical | 170.1B | 54.97 | 8.99 | 16.69% | 28.38% | 0.95 |
| Becton, Dickinson | 56.1B | 25.40 | 1.75 | 6.96% | 8.01% | 77.28 |
| Baxter International | 9.4B | 86.31 | 1.54 | -13.71% | -8.51% | 160.28 |
| AptarGroup | 8.0B | 21.10 | 2.99 | 15.10% | 10.40% | 57.10 |
| Repligen | 7.5B | 154.30 | 3.55 | 2.40% | 6.62% | 32.76 |
Financial data is updated regularly. All figures are in the company's reporting currency.






